• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. AFX; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. AFX; BIFURCATED STENT GRAFT Back to Search Results
Model Number BA22-70/I16-30
Device Problems Bent (1059); Partial Blockage (1065); Off-Label Use (1494); Deformation Due to Compressive Stress (2889)
Patient Problems Failure of Implant (1924); Stenosis (2263)
Event Date 01/09/2018
Event Type  Injury  
Manufacturer Narrative
The devices involved in the event will not be returned for evaluation, they remain implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
This patient had an afx graft placed on (b)(6) 2016 to treat aortic stenosis.Through regular follow up, an updated scan revealed that the main body graft appeared to be pinched in or narrowed a bit at the area of the stenosis.The physician elected to placed a bare metal and balloon expandable stent to open the area.The physician was pleased with the angiographic result and the patient will be monitored moving forward.No additional patient sequelae has been reported at this time.
 
Manufacturer Narrative
Clinical evaluations was unable to find substantial evidence to support the following reported events; off label procedure, aortic stenosis, secondary endovascular procedure, and favorable patient disposition.The most likely cause of the inadequate stent graft patency is the reported off-label use (aortic stenosis and stent buckling).Procedure related harms and the final patient disposition could not be ascertained due to the lack of medical information surrounding the implant or the repair procedure.Reportedly, the patient is doing well; there have been no reports of further negative patient sequelae.Devices remain implanted in the patient and were not returned, no evaluation completed.The review of manufacturing lot confirmed all devices met specifications prior to release.Endologix continues to investigate this event and similar events to ensure the highest quality and patient safety.Correction: udi#, device code: remove 3323, 3263.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
MDR Report Key7251829
MDR Text Key99354450
Report Number2031527-2018-00075
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00818009010094
UDI-Public(01)00818009010094
Combination Product (y/n)N
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 01/09/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Paramedic
Device Expiration Date12/10/2018
Device Model NumberBA22-70/I16-30
Device Lot Number1297632007
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/09/2018
Initial Date FDA Received02/08/2018
Supplement Dates Manufacturer Received04/06/2018
Supplement Dates FDA Received04/11/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
VELA INFRARENAL- LOT: 1264384-017; VELA INFRARENAL- LOT: 1264384-017
Patient Outcome(s) Required Intervention;
Patient Age74 YR
-
-